- Home
- HKIT vs BDRX Comparison
HKIT vs BDRX Comparison
Compare HKIT & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HKIT | BDRX |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | China | United Kingdom |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 2.2M |
| IPO Year | 2018 | 2015 |
Fundamental Metrics
Financial Performance| Metric | HKIT | BDRX |
|---|---|---|
| Price | $0.17 | $2.94 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 31.5M | 46.1K |
| Earning Date | 04-24-2026 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.03 | $0.60 |
| 52 Week High | $8.80 | $11.88 |
Technical Indicators
Market Signals| Indicator | HKIT | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 47.31 |
| Support Level | $0.03 | $2.22 |
| Resistance Level | $0.92 | $3.68 |
| Average True Range (ATR) | 0.07 | 0.29 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 4.35 | 42.24 |
Price Performance
Historical ComparisonAbout HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of business services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from Hardware and equipment sales, Tax services, and Software sales.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.